Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants

NCT02230046 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Abiraterone acetate (Treatment A)
DRUG: Abiraterone acetate (Treatment B)
DRUG: Abiraterone acetate (Treatment B)

Sponsor

Janssen Research & Development, LLC